Nearly 22,000 pounds of fentanyl were seized at US borders during the 2024 fiscal year, according to data from the US Customs ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

Doctors often use different methods to help people manage chronic pain. One common approach is prescribing opioid painkillers. These medicines can be very effective, but they also come with serious ...

GOSHEN – Fellowship trained pain management specialist Andrew Kalin, MD, is currently seeing patients at Goshen Orthopedics. Dr. Kalin specializes in treating patients with chronic pain in the spine, ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

Music therapy is also commonly used in physical rehabilitation. For example, rhythmic auditory stimulation is used to improve ...

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...